Ipca Laboratories Limited (IPCALAB.NS)
INR 1330.95
(2.79%)
INR 1330.95
(2.79%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 48.58 Billion INR | -22.2% |
| 2022 | 39.37 Billion INR | 7.58% |
| 2021 | 36.6 Billion INR | 3.43% |
| 2020 | 35.39 Billion INR | 24.19% |
| 2019 | 28.49 Billion INR | 18.65% |
| 2018 | 24.01 Billion INR | 18.29% |
| 2017 | 20.3 Billion INR | 2.27% |
| 2016 | 19.85 Billion INR | 14.38% |
| 2015 | 17.35 Billion INR | -8.97% |
| 2014 | 19.06 Billion INR | -7.53% |
| 2013 | 20.62 Billion INR | 26.68% |
| 2012 | 16.27 Billion INR | 12.6% |
| 2011 | 14.45 Billion INR | 30.69% |
| 2010 | 11.06 Billion INR | 21.03% |
| 2009 | 9.13 Billion INR | 17.7% |
| 2008 | 7.76 Billion INR | 32.25% |
| 2007 | 5.87 Billion INR | 9.17% |
| 2006 | 5.37 Billion INR | 153.92% |
| 2005 | 2.11 Billion INR | 3.48% |
| 2004 | 2.04 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 8.62 Billion INR | 10.14% |
| 2023 FY | 30.63 Billion INR | -22.2% |
| 2023 Q1 | 10.72 Billion INR | 16.49% |
| 2023 Q2 | 13.56 Billion INR | 26.5% |
| 2023 Q3 | 13.55 Billion INR | -0.03% |
| 2023 Q4 | 7.82 Billion INR | -42.25% |
| 2022 Q2 | 10.26 Billion INR | 1.9% |
| 2022 Q3 | 9.84 Billion INR | -4.09% |
| 2022 Q4 | 9.2 Billion INR | -6.47% |
| 2022 FY | 39.37 Billion INR | 7.58% |
| 2022 Q1 | 10.07 Billion INR | 42.14% |
| 2021 Q4 | 7.08 Billion INR | -23.98% |
| 2021 Q1 | 10.2 Billion INR | 63.59% |
| 2021 Q2 | 10 Billion INR | -1.97% |
| 2021 Q3 | 9.31 Billion INR | -6.81% |
| 2021 FY | 36.6 Billion INR | 3.43% |
| 2020 FY | 35.39 Billion INR | 24.19% |
| 2020 Q4 | 6.23 Billion INR | -30.28% |
| 2020 Q3 | 8.94 Billion INR | -2.61% |
| 2020 Q2 | 9.18 Billion INR | -16.56% |
| 2020 Q1 | 11 Billion INR | 98.53% |
| 2019 FY | 28.49 Billion INR | 18.65% |
| 2019 Q4 | 5.54 Billion INR | -29.73% |
| 2019 Q3 | 7.89 Billion INR | -5.41% |
| 2019 Q2 | 8.34 Billion INR | 24.1% |
| 2019 Q1 | 6.72 Billion INR | 52.33% |
| 2018 Q2 | 6.99 Billion INR | 17.74% |
| 2018 Q1 | 5.93 Billion INR | 0.0% |
| 2018 FY | 24.01 Billion INR | 18.29% |
| 2018 Q4 | 4.41 Billion INR | -33.87% |
| 2018 Q3 | 6.67 Billion INR | -4.58% |
| 2017 FY | 20.3 Billion INR | 2.27% |
| 2016 FY | 19.85 Billion INR | 14.38% |
| 2015 FY | 17.35 Billion INR | -8.97% |
| 2014 FY | 19.06 Billion INR | -7.53% |
| 2013 FY | 20.62 Billion INR | 26.68% |
| 2012 FY | 16.27 Billion INR | 12.6% |
| 2011 FY | 14.45 Billion INR | 30.69% |
| 2010 FY | 11.06 Billion INR | 21.03% |
| 2009 FY | 9.13 Billion INR | 17.7% |
| 2008 FY | 7.76 Billion INR | 32.25% |
| 2007 FY | 5.87 Billion INR | 9.17% |
| 2006 FY | 5.37 Billion INR | 153.92% |
| 2005 FY | 2.11 Billion INR | 3.48% |
| 2004 FY | 2.04 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -81.415% |
| Hester Biosciences Limited | 1.27 Billion INR | -3714.557% |
| Aarti Drugs Limited | 8.31 Billion INR | -484.21% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -733.153% |
| Albert David Limited | 1.4 Billion INR | -3350.362% |
| Alembic Limited | 1 Billion INR | -4757.89% |
| Alkem Laboratories Limited | 52.29 Billion INR | 7.099% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -10645.058% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -3200.985% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -387178.597% |
| Brooks Laboratories Limited | 65.62 Million INR | -73938.555% |
| Eris Lifesciences Limited | 10.42 Billion INR | -365.955% |
| FDC Limited | 6.58 Billion INR | -637.664% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -290.768% |
| Gufic Biosciences Limited | 4.07 Billion INR | -1092.619% |
| Hikal Limited | 5.95 Billion INR | -715.443% |
| Ind-Swift Limited | 2.17 Billion INR | -2136.29% |
| Innova Captab Limited | 3.46 Billion INR | -1302.365% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -929.52% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -7344.812% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -147.335% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -2474.857% |
| Lupin Limited | 125.09 Billion INR | 61.162% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -6929.021% |
| Medico Remedies Limited | 262.14 Million INR | -18433.363% |
| Morepen Laboratories Limited | 6.16 Billion INR | -688.539% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -907.281% |
| Orchid Pharma Limited | 2.32 Billion INR | -1993.869% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -740.352% |
| RPG Life Sciences Limited | 2.48 Billion INR | -1856.669% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -7730.121% |
| Sigachi Industries Limited | 2 Billion INR | -2326.435% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 3034.0% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -1078.289% |
| Themis Medicare Limited | 2.42 Billion INR | -1907.602% |
| Unichem Laboratories Limited | 4.86 Billion INR | -898.66% |
| Vaishali Pharma Limited | 90.32 Million INR | -53689.29% |
| Wanbury Limited | 1.73 Billion INR | -2707.286% |
| Windlas Biotech Limited | 1.33 Billion INR | -3528.929% |
| ZIM Laboratories Limited | 1.26 Billion INR | -3732.119% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -1075.455% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 81.204% |
| Venus Remedies Limited | 2.18 Billion INR | -2125.989% |
| Sakar Healthcare Limited | 699.58 Million INR | -6844.703% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 55.649% |
| Divi's Laboratories Limited | 32.44 Billion INR | -49.766% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -680.756% |
| Mankind Pharma Limited | 42.19 Billion INR | -15.136% |
| Sequent Scientific Limited | 2.97 Billion INR | -1531.034% |
| Laurus Labs Limited | 15.44 Billion INR | -214.487% |
| Neuland Laboratories Limited | 8.24 Billion INR | -489.053% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -218.398% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 29.934% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 61.198% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -2220.117% |
| Wockhardt Limited | 7.72 Billion INR | -529.328% |
| Bal Pharma Limited | 770.19 Million INR | -6208.026% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 70.304% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -1214.706% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -9081.779% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -427.715% |
| Shilpa Medicare Limited | 3.56 Billion INR | -1263.995% |
| Valiant Laboratories Limited | 138.02 Million INR | -35098.473% |
| Ajanta Pharma Limited | 21.06 Billion INR | -130.65% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -42883.748% |
| Granules India Limited | 16.79 Billion INR | -189.203% |
| Medicamen Biotech Limited | 495.49 Million INR | -9705.165% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -8583.439% |
| Piramal Enterprises Limited | 8.04 Billion INR | -504.032% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -3.907% |
| NATCO Pharma Limited | 25.73 Billion INR | -88.779% |
| Suven Life Sciences Limited | -200.79 Million INR | 24295.63% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 44776.267% |
| Strides Pharma Science Limited | 14.38 Billion INR | -237.668% |
| Indoco Remedies Limited | 8.04 Billion INR | -504.054% |
| Alpa Laboratories Limited | 188.89 Million INR | -25620.162% |
| Lasa Supergenerics Limited | 121.02 Million INR | -40042.196% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -12323.504% |